Rahem Rahmati: Toxic Epidermal Necrolysis in a Pregnant IVF Patient on Hydroxychloroquine
Rahem Rahmati, Executive Secretary at Student Research and Technology Committee, shared a post on LinkedIn about a paper published in Clinical Case Reports:
“A reminder that even established treatments can have rare, severe consequences.
Our latest case report details a pregnant IVF patient who developed life-threatening Toxic Epidermal Necrolysis (TEN) after taking hydroxychloroquine for recurrent implantation failure.
Title: Toxic Epidermal Necrolysis and Recurrent Implantation Failure: Unveiling a Rare Phenomenon During Pregnancy
Authors: Hatav Ghasemi Tehrani, Faezeh Zakerinasab, Negar Khalili Geshnigani, Rahem Rahmati, Nastaran Zamani Dehkordi
Read the full article.

Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 11, 2025, 06:44The Global IVF Market Is Set to Reach $65B by 2032 – Meddilink
-
Feb 4, 2026, 00:43Join the 2026 Rising Stars Webinar On February 11 – SSR
-
Feb 4, 2026, 00:18Dalia Alqarni: Urinary Incontinence’s Impact on Women’s Health
-
Feb 4, 2026, 00:16New Study Reveals IVF Success for Women With Endometriosis – Fertility Plus
-
Feb 4, 2026, 00:13Tamuka Chekero: Exploring Relational Autonomy in Infertility Across Cultures
-
Feb 2, 2026, 13:04Optimal GnRH Agonist Dosage for Oocyte Maturation – Fertility and Sterility
-
Feb 2, 2026, 12:39Family Planning Challenges for Women with Lupus – The Lupus Foundation of Australasia
-
Feb 2, 2026, 12:17Anis Feki: Innovative Strategies for Bowel Endometriosis Management
-
Feb 2, 2026, 12:10Revolutionizing Testicular Cell Cultivation with 3D Bioprinting – School of Infection, Inflammation and Immunology, University of Birmingham
-
Feb 2, 2026, 12:07Cesar Diaz Garcia: Age and Its Impact on Male Fertility
